Overview
Microform holoprosencephaly (also known as microform HPE or holoprosencephaly microform) is the mildest end of the holoprosencephaly (HPE) spectrum, a group of disorders resulting from incomplete division of the forebrain (prosencephalon) during early embryonic development. Unlike the more severe forms of holoprosencephaly (alobar, semilobar, and lobar), microform HPE is characterized by subtle midline facial abnormalities without the typical structural brain malformations seen on standard neuroimaging. Affected individuals may present with features such as a single central maxillary incisor (solitary median maxillary central incisor), hypotelorism (closely spaced eyes), midface hypoplasia, microcephaly, or anosmia (absent sense of smell). Cognitive function can range from normal to mildly impaired, though some individuals may have more significant neurological involvement. Microform HPE is caused by mutations in genes known to be involved in the holoprosencephaly spectrum, including SHH (Sonic Hedgehog), ZIC2, SIX3, TGIF1, and others. The condition demonstrates significant phenotypic variability, even within the same family carrying the same mutation, which is a hallmark of the HPE spectrum. Environmental factors such as maternal diabetes may also contribute to disease expression. Chromosomal abnormalities, including deletions and duplications affecting HPE-related loci, can also be causative. There is no cure for microform holoprosencephaly, and management is supportive and symptom-based. Dental anomalies, particularly the single central incisor, may require orthodontic intervention. Endocrine evaluation is recommended, as some patients may have pituitary dysfunction leading to growth hormone deficiency or other hormonal imbalances. Genetic counseling is essential for affected families, given the autosomal dominant inheritance pattern with variable expressivity and reduced penetrance observed in many cases. Regular developmental monitoring and neuropsychological assessment may be beneficial for children with this condition.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Microform holoprosencephaly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Microform holoprosencephaly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Microform holoprosencephaly.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Microform holoprosencephaly.
Community
No community posts yet. Be the first to share your experience with Microform holoprosencephaly.
Start the conversation →Latest news about Microform holoprosencephaly
No recent news articles for Microform holoprosencephaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Microform holoprosencephaly
What is Microform holoprosencephaly?
Microform holoprosencephaly (also known as microform HPE or holoprosencephaly microform) is the mildest end of the holoprosencephaly (HPE) spectrum, a group of disorders resulting from incomplete division of the forebrain (prosencephalon) during early embryonic development. Unlike the more severe forms of holoprosencephaly (alobar, semilobar, and lobar), microform HPE is characterized by subtle midline facial abnormalities without the typical structural brain malformations seen on standard neuroimaging. Affected individuals may present with features such as a single central maxillary incisor (
At what age does Microform holoprosencephaly typically begin?
Typical onset of Microform holoprosencephaly is neonatal. Age of onset can vary across affected individuals.